Impella Support as a Bridge to Surgery for Severe Mitral Regurgitation With Cardiogenic Shock-Reference-Cited by-同舟云学术

Impella Support as a Bridge to Surgery for Severe Mitral Regurgitation With Cardiogenic Shock

Published:2021-03-10 Issue:3 Volume:3 Page:178-181
ISSN:2434-0790
Container-title:Circulation Reports
language:en
Short-container-title:Circ Rep

Author:

Imaoka Shusuke¹,Kainuma Satoshi¹,Toda Koichi¹,Miyagawa Shigeru¹,Yoshioka Daisuke¹,Kawamura Takuji¹,Kawamura Ai¹,Kashiyama Noriyuki¹,Nakamoto Kei²,Takeda Yasuharu²,Sakata Yasushi²,Sawa Yoshiki¹

Affiliation:

1. Department of Cardiovascular Surgery, Osaka University Graduate School of Medicine

2. Department of Cardiology, Osaka University Graduate School of Medicine

Publisher

Japanese Circulation Society

Subject

Marketing,Organizational Behavior and Human Resource Management,Strategy and Management,Drug Discovery,Pharmaceutical Science,Pharmacology

Link

https://www.jstage.jst.go.jp/article/circrep/3/3/3_CR-21-0016/_pdf

Reference5 articles.

1. 1. Akodad M, Schurtz G, Adda J, Leclercq F, Roubille F. Management of valvulopathies with acute severe heart failure and cardiogenic shock. Arch Cardiovasc Dis 2019; 112: 773–780.

2. 2. Lorusso R, Gelsomino S, De Cicco G, Beghi C, Russo C, De Bonis M, et al. Mitral valve surgery in emergency for severe acute regurgitation: Analysis of postoperative results from a multicentre study. Eur J Cardiothorac Surg 2008; 33: 573–582.

3. 3. Chung JS, Emerson D, Ramzy D, Akhmerov A, Megna D, Esmailian F, et al. A new paradigm in mechanical circulatory support: 100-Patient experience. Ann Thorac Surg 2020; 109: 1370–1377.

4. 4. Nalluri N, Patel N, Saouma S, Anugu VR, Anugula D, Asti D, et al. Utilization of the Impella for hemodynamic support during percutaneous intervention and cardiogenic shock: An insight. Expert Rev Med Devices 2017; 14: 789–804.

5. 5. Konstantinou K, Keeble TR, Kelly PA, Alsanjari O, Napp LC, Karamasis GV, et al. Protected percutaneous coronary intervention with Impella CP in a patient with left main disease, severe left ventricular systolic dysfunction and established hemolysis. Cardiovasc Diagn Ther 2019; 9: 194–199.

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Use of percutaneous ventricular assist device as bridge to high risk combined heart valve surgery;Acta Cardiologica;2024-04-08

2. Surgical Explantation of Impella 5.5 With Inflow Thrombus in Patients Undergoing Durable Left Ventricular Assist Device Implantation;Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery;2023-09

3. Mitral regurgitation in the critically ill: the devil is in the detail;Annals of Intensive Care;2023-08-02

4. One-week Impella CP support for papillary muscle rupture as a bridge to surgery: a case report;European Heart Journal - Case Reports;2023-07

5. Escalation from impella 5.5 to ECPELLA support as a bridge to mitral valve surgery in a patient with degenerative mitral regurgitation;Perfusion;2023-06-24